1235
     RDKit          2D

 14 14  0  0  1  0  0  0  0  0999 V2000
    2.0930   -1.7779    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    2.3472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -2.6029    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    2.3472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.6971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.6971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    1.1096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -0.1279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.5404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.5404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    1.9347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -1.7779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2 12  1  0
  3 14  1  0
  4 12  2  0
  6  7  1  0
  6  8  1  0
  7  5  1  1
  7 12  1  0
  8  9  2  0
  8 10  1  0
  9 11  1  0
 10 13  2  0
 11 14  2  0
 13 14  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB01235

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
APRD00309; EXPT01107

>  <COMMON_NAME>  (1) 
Levodopa

>  <CAS_NUMBER>  (1) 
59-92-7

>  <UNII>  (1) 
46627O600J

>  <SYNONYMS>  (1) 
(−)-3-(3,4-dihydroxyphenyl)-L-alanine; (−)-dopa; 3-Hydroxy-L-tyrosine; 3,4-Dihydroxy-L-phenylalanine; Dihydroxy-L-phenylalanine; L-3,4-dihydroxyphenylalanine; L-beta-(3,4-Dihydroxyphenyl)alanine; L-DOPA; Levodopa; Levodopum; β-(3,4-dihydroxyphenyl)-L-alanine; β-(3,4-dihydroxyphenyl)alanine

$$$$
